These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8509406)

  • 1. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes.
    Tanaka M; Jingami H; Otani H; Cho M; Ueda Y; Arai H; Nagano Y; Doi T; Yokode M; Kita T
    J Biol Chem; 1993 Jun; 268(17):12713-8. PubMed ID: 8509406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Tanaka M; Otani H; Yokode M; Kita T
    Atherosclerosis; 1995 Apr; 114(1):73-82. PubMed ID: 7605378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
    Avramoglu RK; Cianflone K; Sniderman AD
    J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ; Barrett PH; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
    Wu X; Sakata N; Lui E; Ginsberg HN
    J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
    J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
    Borradaile NM; de Dreu LE; Barrett PH; Huff MW
    J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver.
    Tarugi P; Nicolini S; Ballarini G; Marchi L; Duvigneau C; Tartoni P; Calandra S
    J Lipid Res; 1996 Mar; 37(3):493-507. PubMed ID: 8728313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
    Dashti N
    J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
    Carr TP; Hamilton RL; Rudel LL
    J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
    Brown A; Wiggins D; Gibbons GF
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
    Dashti N; Franklin FA; Abrahamson DR
    J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Ito K; Kasanuki N; Koga T
    J Atheroscler Thromb; 2004; 11(1):22-8. PubMed ID: 15067195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.
    Ginsberg HN; Le NA; Short MP; Ramakrishnan R; Desnick RJ
    J Clin Invest; 1987 Dec; 80(6):1692-7. PubMed ID: 3680522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
    Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.
    Liza M; Chico Y; Fresnedo O; Ochoa B
    Lipids; 2003 Jan; 38(1):53-63. PubMed ID: 12669820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Wilcox LJ; Borradaile NM; de Dreu LE; Huff MW
    J Lipid Res; 2001 May; 42(5):725-34. PubMed ID: 11352979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells.
    Ooyen C; Zecca A; Bersino AM; Catapano AL
    Atherosclerosis; 1999 Jul; 145(1):87-95. PubMed ID: 10428299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.